Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Convenient, transparent pricing with no insurance required
Currently, there are no generic alternatives available, which contributes to the high cost of these brand-name drugs
*Inclusion in Pharma Fridays does not suggest an endorsement by Endocrine News or the Endocrine Society.
The SURMOUNT-4 trial demonstrated that patients who discontinued tirzepatide after achieving weight loss regained significant weight compared to those who continued treatment, though not all weight loss was reversed during the study period
A double-blind, placebo controlled, randomized withdrawal design study (Study 13) was conducted to evaluate maintenance of efficacy based on time to relapse between VYVANSE and placebo in adults aged 18 to 55 (N=267) with moderate to severe BED
ConsumerLab reviews the ingredients in AG1, its safety and possible side effects, and how AG1 compares to other products
US$ 23.02
US$ 28.23
US$ 23.23
US$ 20.87
US$ 25.37
US$ 29.75
US$ 27.37
US$ 22.32
US$ 29.62
US$ 25.86
